Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Researchers should follow the FACE-Q User's Guide for accurate results.

Direct-to-consumer teledermatology is not effectively reaching underserved populations due to language, technology, and insurance barriers.

The treatment was not recommended due to limited effectiveness and significant side effects.

Trichilemmal carcinoma shares genetic changes with other skin cancers, suggesting similar causes and potential treatments.

The study showed that a specific DNA sequence can control gene expression in hair growth areas of mice.

The combination therapy was effective and well-tolerated, especially in young patients.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

WAA-QOL measures impact of hair loss on women's well-being.

Tumor-targeted drug carriers can improve chemotherapy precision and reduce side effects.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

The HAIR-Q is a reliable tool for assessing patient satisfaction with hair loss treatments.

Scalp cooling therapy helped over 80% of women keep at least half their hair during chemotherapy.

The project aimed to understand how genetic test results affect patients' actions and feelings in dermatology.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

The JCCP's Premises Standards aim to make non-surgical cosmetic treatments safer and higher quality.

The document provides a quiz for physicians to earn continuing medical education credits in facial plastic surgery.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

The new tool helps measure the impact of alopecia areata on children's quality of life.

A 23-year-old man has a benign, non-progressive hair loss patch that doesn't respond to treatment but can be cosmetically treated.

Tofacitinib may help regrow hair in alopecia areata patients.

Topical GT20029 effectively promotes hair regrowth and is well-tolerated.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Use personalized cosmeceuticals for safe, effective hair and scalp treatment.

The Brazilian version of the Alopecia Areata Quality of Life Index is reliable for assessing patients' quality of life.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

Cryotherapy with precise temperature control is a promising treatment for alopecia areata.

Cassia HPTC is an effective hair conditioner, better than some traditional formulas.